Background: Medication errors in chemotherapy are frequent and lead to patient morbidity and mortality, as well as increased rates of re-admission and length of stay, and considerable extra costs. Objective: This study investigated the proposition that computerised chemotherapy ordering reduces the incidence and severity of chemotherapy protocol errors. Method: A computerised physician order entry of chemotherapy order (C-CO) with clinical decision support system was developed in-house, including standardised chemotherapy protocol definitions, automation of pharmacy distribution, clinical checks, labeling and invoicing. A prospective study was then conducted in a C-CO versus paper based chemotherapy order (P-CO) in a 30-bed chemotherapy bay of a tertiary hospital. Both C-CO and P-CO orders, including pharmacoeconomic analysis and the severity of medication errors, were checked and validated by a clinical pharmacist. A group analysis and field trial were also conducted to assess clarity, feasibility and decision making. Results and Conclusion: The C-CO was very usable in terms of its clarity and feasibility. The incidence of medication errors was significantly lower in the C-CO compared with the P-CO (10/3765 [0.26%] versus 134/5514 [2.4%]). There was also a reduction in dispensing time of chemotherapy protocols in the C-CO. The chemotherapy computerisation with clinical decision support system resulted in a significant decrease in the occurrence and severity of medication errors, improvements in chemotherapy dispensing and administration times, and reduction of chemotherapy cost.
Introduction
Globally, adverse drug events (ADEs) and medication errors (MEs) are significant problems (Zafar et al. 2008 ). An adverse drug event is an injury resulting from medical intervention related to a drug, which can be attributed to either preventable or non-preventable causes. Adverse reactions to medications can either be unpredictable, such as idiosyncratic or unexpected allergic responses, or predictable, which are related to the inherent pharmacologic properties of the drug (Leape 1995) . In general, the number and severity of adverse medication reactions are directly related to the number of drugs administered (The Joint Commission 2014) .
In chemotherapy prescribed for cancer patients, anticancer drugs are designed to kill cancer cells or slow their growth. Different drugs may be combined together under the system of rules according to an agreed standard regimen called the Standardized Chemotherapy Protocol (Mayer 2009 ). Most drug and surgical treatment regimens for hospitalised patients have the potential for undesirable side effects, and therefore cancer patient undergoing chemotherapy may be at risk of adverse drug events and medication errors (Brennan et al. 1991) . Adverse drug reactions are not preventable as such, but medication errors occur as a result of human mistakes or system flaws that can be prevented. A medication error can be defined as:
Medication errors are possible at any step of the process, such as chemotherapy selection and order transcription, as well as drug formulation/ compounding, dispensing and administration. It has also been observed that several problems can arise in the chemotherapy ordering process itself, with the potential for dangerous and costly outcomes (Ranchon et al. 2011) .
The sources of medication errors may be multidisciplinary and multifactorial. Errors may occur from lack of knowledge, substandard performance, mental lapses and defects or failures in systems (Schwappach & Wernli 2010) . Errors are sometimes committed by both experienced and inexperienced staff involved in the drug delivery process, including pharmacists, physicians, nurses, supportive personnel (such as pharmacy technicians and assistant nurses), students, clerical staff, administrators, pharmaceutical manufacturers, and patients and their caregivers (Latif et al. 2013) .
The pharmacist's responsibility is to help and ensure that patients make the best use of medications. Through a system-oriented approach, pharmacists should collaborate with physicians, nurses, and administrators to prevent, detect, and resolve drug-related problems causing harm to patients and to improve the safety of medication delivery processes (Wang et al. 2011) . To accomplish the above, pharmacists should also participate in appropriate committees in their organisations.
Information technology is emerging rapidly in healthcare settings. Systems including clinical decision support, fast access to clinical data and vast functionalities are now available to healthcare professionals at their workstations. It is evident that information technology has major advantages, but there are also some risks associated with the information systems operating within our healthcare environment. Some systems, for example, are costly, while others are not appropriately designed, resulting in more time being spent by healthcare professionals with the computer than the patient (Ammenwerth et al. 2002) .
Feasibility and acceptability of hospital information systems to improve prescribing behaviour in healthcare settings need to be addressed, and the strengths and weaknesses of different information system tools should be explored to facilitate their implementation. System cost is a major parameter that cannot be neglected, so it is important to analyse the balance between costs and benefits. Such evaluations are essential to optimise the HIS for current and future users (Ammenwerth et al. 2002; Martens et al. 2007) .
Physicians manage many complex tasks and are expected to act professionally by adhering to various complicated therapeutic guidelines in a limited time. In addition, the opportunities for continuing education in primary care are limited and are tending to diminish, all of which contributes to increased chances of medication errors. Computerised physician order entry, standardised order forms, and alert systems are demonstrably successful in decreasing errors. These systems help the attending physician to review and override the embedded template filled by residents (Devine et al. 2010; Sultan et al. 2014) . A study of indication-based alerts which indicated a wrongpatient medication error interception rate of 0.25 per 1000 alerts (Galanter et al. 2012) suggests the need of use of such systems.
In the context of the foregoing discussion, a computerised physician order entry of chemotherapy order (C-CO) with clinical decision support system modules (CDSS), integrated with existing hospital information system (HIS) was developed to explore the following: feasibility and acceptability for the use of the locally developed system efficiency of the system in reducing medication errors and other problems inherent in paper based orders usability of the system to decrease the prescribing time and to increase the awareness and knowledge of health providers about how to use and manage chemotherapy protocols correctly possibility of the system to help prescribers in decision making of selected parameters through one window.
Method
A prospective, controlled cross-sectional comparative study was conducted in paper-based chemotherapy order (P-CO) versus computerised physician order entry of chemotherapy order (C-CO) in a chemotherapy bay in a tertiary hospital, Lahore, Pakistan. The C-CO application was evaluated six months after the implementation of the chemotherapy module.
Evaluation of usability
Continually rotating medical staff consisting of residents, consultants, nurses, and pharmacists were selected as evaluators for chemotherapy module usability, clarity and clinical decision making during chemotherapy ordering. They were divided into four groups based on their specialty. The selection criteria for all participants were: having at least one year of field experience in the respective clinical departments; and general in-house HIS computer literacy. The physicians were selected from the adult oncology department as required by the proposed C-CO system. The medical staff first experienced the C-CO on a daily basis for a period of one week. To use C-CO, the participant was given the authenticated rights to log on. They had access to respective menus to run the system individually. Ten to fifteen minutes were allocated for each session, which was conducted in the respective area of each group. The concerned medical staff were allowed to repeat their sessions with different regimens.
The usability and acceptability of the C-CO were then tested by Shneiderman's questionnaire method (Shneiderman 1992 ) and Hix and Hartson's usability specifications testing procedure (Hix & Hartson 1997) . Under the questionnaire method, usability and acceptability were tested using a questionnaire with Likert type indicators. The questionnaire was designed so that it could help to evaluate clarity, feasibility and decision making. The participants' responses to the questionnaire were evaluated on an 11-point scale ranging from zero to 10. The questionnaire was validated for overall indication of the module's usability. Each participant was asked to complete the questionnaire before and after their experience using the module. The first two sessions were held in all four groups back to back, with all 20 participants.
Medication errors evaluation
A clinical pharmacist with experience in medication errors analysed all chemotherapy orders and recorded every possible medication error. The transcription errors in the P-CO were also taken into account. The clinical pharmacist collected information out of the patient chemotherapy file, which include nursing notes and laboratory reports. Different parameters, including pharmacists' interventions and medications errors in the C-CO, were compared with the P-CO using a specific validated clinical intervention form.
Pharmacy chemotherapy protocol dispensing time
The chemotherapy dispensing time was also identified and recorded in terms of pharmaceutical preparation and administration for both the C-CO and P-CO. A time and motion study was adopted to compare the chemotherapy protocol dispensing and administration time of the C-CO and P-CO. These studies are useful in comparing two work methods that produce an identical output if the starting points and endpoints are identical (Burke et al. 2000) . For the P-CO, an external observer captured the data continuously over 12 chemotherapy protocols by using a stopwatch to measure the time a staff member took to accomplish the activities of both chemotherapy dispensing and administration. Chemotherapy protocols prescribed in higher numbers were selected for this study. A computer generated report was utilised to measure the amount of time spend by medical staff in chemotherapy dispensing and administration. The scope of the time and motion study started from the ordering of chemotherapy protocol and ended at administration by nurses. Pharmacy dispensing time (started from the ordering of the chemotherapy protocol to the release of chemotherapy) and drug administration (started from receiving of the drugs from the pharmacy to finish time of administration) were calculated for both the P-CO and the C-CO.
Review of pharmacoeconomics impact
Pharmacoeconomics impact in terms of medication use identified during clinical interventions was recorded. 'Cost decrease', 'cost increase', 'no change in cost' and 'increase cost in therapy' were the factors utilised to assess the pharmacoeconomic impact. The actual cost of the C-CO system including manpower, software and hardware cost were not evaluated.
Design and development of the C-CO
Before designing the C-CO systems, initial requirements for the system were ascertained in discussion with consultant oncologists and the Resident. A separate discussion was also carried out with the Management Information System (MIS) department to design the definition form of the Chemotherapy Protocol (see Figure 1 ). Based on this discussion, the initial requirements were incorporated into the system in order to fulfill them.
The C-CO was developed as a menu driven application on the HIS, to facilitate navigation between different areas of the application. A standard screen design was followed throughout the application, so that the application remained consistent as well as easy to follow. The tools used for the development of the module included the back end, Oracle 8i/9i, Front End Developer 6/6i/9i and Designing Tools, ER-Win and Rational Rose.
The network bandwidth speed for the backbone was provided with 1Gbps, 100Mbps bandwidth to nodes and 1Gbps bandwidth was given to the special locations such as image viewing stations and nodes. The server was loaded with 64GB of physical memory and was used exclusively for C-CO to safeguard it against any error, intentional or unintentional. Data security and privacy were maintained in a dual way using Oracle's inbuilt security and Application Level Auditing, to keep track of all transactions carried out at the front end (by our clients) and by users (at the backend).
In recent years, computational intelligence has been used to solve complex problems by developing intelligent systems. Fuzzy logic, analysis design including 'If-Then-Else' are few examples of intelligent systems being used to address the complexity. Fuzzy logic has proved to be a wonderful tool for decision making systems and is designed to serve as a decision support for correct dose administration, including dose adjustment. Fuzzy logic works with and builds on a set of user input human language rules. The fuzzy systems convert these rules into their exact accurate equivalents. This streamlines the job of the developers and the computer function, and results in precise and accurate representation of the way systems behave in the real world (Deva et al. 2011; Soundararajan, Sureshkumar & Anusuya 2012) . Fuzzy logic and analysis design were created in the system since it shortens the time for engineering development and sometimes in the case of highly complex systems; this is the only way to solve the problems. 'If-Then-Else' condition was used more often in C-CO development.
A flexible coding system with generic style was used in the system to allow for easy control over the functionality of the whole application. Definition tables were used to define different chemotherapy order parameters. The C-CO operated with both active and passive clinical decision support modules. Automation of applications with alerts and pop-ups were created, which helps the users to make active and passive decisions.
The components of the C-CO included the chemotherapy protocol definition, physician menu, chemotherapy order, chemotherapy pharmacist form, including pharmacy operations with clinical checks, automatic labeling and chemotherapy invoicing. Under the CDSS, two sub-modules were the Chemotherapy Protocol (definition form) and chemotherapy order form (physician menu). Other system components, alerts and pop-ups include: drug allergy alert dosage alert life time dosage alerts drug-drug interaction alerts lab-adjustment alerts recent labs details including critical labs pop ups weight alerts if differ from the last reading (if difference is >5%).
System validation and testing
Initially the system was validated by utilising it only for breast cancer for one month on a daily basis to test for any error whereby the prescriber made orders on the chemotherapy protocol from the system. Debugging and trouble-shooting were done during the validation trial of the chemotherapy order. 
Results
A summary of data gathered from the questionnaire that was given to the four groups of participants is shown in Table 1 . The mean score of all groups was higher in 'human decision support limitation' while it was lower in 'chemo protocol organisation and decision making' (9.4 vs. 4.6). The mean score for 'operations relate to tasks' to nurse was very low in comparison with pharmacist (5.9 vs. 9.2), which was the highest score within all groups. The mean score for 'Sequence of display' was high for consultants and lowest for nurses (9.1 vs. 6.8). The module feasibility function was more popular with the pharmacist, consultant and resident while nurses showed less interest. The mean score of 'decision making' was low but pharmacists were the more satisfied group identified during the study. All except nurses strongly recommended the C-CO application as being userfriendly and helpful in decision making. It is also observed that most of the nurses are not frequent computer users and thus they were less able to organise and handle the C-CO appropriately. A total of 5514 and 3765 chemotherapy protocol orders of the P-CO and the C-CO were monitored respectively. The number of medication errors was higher in P-CO (n = 134) than C-CO (n=10) including higher percentage of pharmacy interventions (2.43 vs. 0.26) ( Table 2 ). The pharmacy intervention acceptance rate was higher (85.3 vs. 91.1%) in C-CO showing higher accuracy due to CDSS. The clinical activities identified during interventions with the P-CO were higher when compared to the C-CO. Sixty-five pharmacy interventions were identified in dosage calculation with P-CO, while only two were detected with the C-CO (Table 4) . The number and severity of pharmacy interventions recorded during C-CO was very low in comparison with P-CO. In P-CO, pharmacy intervention severity was fatal in one case, 48 cases were serious, and 85 were significant. However, in case of C-CO, two cases were serious, eight were significant and none of the cases was fatal (Table 3 ). This finding suggests that the C-CO effectively reduces medication errors. P-CO = Paper based chemotherapy order C-CO = Computerised physician order entry of chemotherapy order
The impact of pharmacy interventions on the cost of therapy was reviewed. Overall, the P-CO raised the cost of 54 cases as compared to none in case of the C-CO. In more than 50% of the cases, the cause of cost fluctuations was unknown. The P-CO had seven cases with no change in cost, but no case in the C-CO (Table 5) . Table 5 Chemotherapy protocol dispensation time including administration was calculated by utilising a time and motion study. Pharmacy delays of the P-CO were higher as compared to the C-CO (28.3% versus 12.3%: see Table 6 ). High stability drugs delivered well on time before the arrival of the patients (Zero time) while the maximum time of delay was 390 minutes observed during the P-CO and 260 minutes during the C-CO. Average administration time was 132 and 112 minutes for the P-CO and C-CO respectively (see Figure 2&3 ). 
Discussion
Results indicate that computerised physician order entry of chemotherapy order systems (C-CO) makes a significant difference in rational prescribing and reducing medication errors, and also helps healthcare professionals in clinical decision-making before ordering C-CO. Overall, C-CO reduces the drug delivery time from the time of ordering to administration because online ordering made the appointment automatically very quickly, keeping in view the time of administration required for specific chemotherapy protocols. Previously, nurses were required to monitor the process manually, resulting in long waiting hours for patients before drug administration. Furthermore, for emergency patients the drug delivery time has been reduced as compared to the previous manual system since the chemotherapy orders from the C-CO are automatically viewed and cleared quickly from respective departments.
The present findings were in line with the earlier reports on the use of automated systems. The CDSS, using computers, has long been promoted for its potential to improve the quality of healthcare (Jaspers et al. 2011 ). It has already been shown that the C-CO has reduced medication errors and promoted rational prescribing. HIS, like any healthcare information system, has to meet user requirements and user expectations for being accepted and used properly in an institution. Even individuals who have been accustomed to using the paper environment and found it difficult to accept or adapt to this change, and who regarded the existing paper system purely as an information system, are using the C-CO efficiently. User involvement from the beginning, as well as education and training, are fundamental to success. (Noudoostbeni et al. 2010; Aristomenis 2006; Tsai & Hung 2008; Wu & Wang 2006) .
There are compelling theoretical reasons why providing a prescriber with a computer system should have a positive effect on quality-of-life outcomes for patients. This was consistent with the observation that the prescribers, nurses, and pharmacists in field trials and in groups performed better when using a C-CO rather than traditional paper-based methods. The alert system in the C-CO increases the awareness and knowledge of the prescriber of important information which could be overlooked during prescription. For example, if information such as patient renal function, complete blood count (CBC), hepatic function and pharmacokinetics are initially overlooked, a pop-up alert in the C-CO automatically assists the prescriber's decision-making. Prescribers encountered these alerts several times a day during chemotherapy ordering and thus physicians benefit from increased awareness and knowledge of these problems throughout the system.
In general, all medical staff accurately predicted that using a C-CO would reduce many problems that they had encountered with the P-CO. They agreed that the C-CO would also help them a great deal, whereas nurses predicted that it would slow down their work. Some nurses were critical of some of the C-CO features, including clearance of patients after invoicing for chemotherapy, receiving medication from the pharmacy and the requirement for endorsement by two nurses that made their work somewhat more difficult. However, the overall results suggest that it would be reasonable to consider using a C-CO because of its potential to reduce medication errors and promote rational prescribing.
It has been suggested that pharmacists should participate in appropriate organisational committees and work with physicians, nurses, administrators, and others to evaluate and improve systems to ensure that medication processes are safe. This requires the establishment of a clearly defined system for drug ordering, dispensing, and administering that includes the review of the original drug order by appropriate pharmacy and nursing staff before dispensing and administration. CPOE, a computerised record for medication administration and individual patient bar coding medication administration are examples of such systems (Vecchione 2002) .
Templates or standardised order forms can also aid in drug choice or delivery method (Grissinger 2002 ). Yet complete reliance on computer systems is not failsafe; one third of software systems fail to trigger an alert for clinically significant drug-drug interactions (Hazlet et al. 2001) . Only 2% of erroneous medication orders reach the patient (Marino et al. 2000) . However, in the present study, after C-CO implementation, fewer such problems were evident.
Limitations
Due to the descriptive nature of the study, inferential statistics were not calculated. The author considers this a weakness of the study.
Conclusion
Computerised physician order entry of chemotherapy order (C-CO) with a CDSS significantly reduces the frequency of medication errors, promotes rational prescribing and leads to a considerably shorter time needed to deliver services to patients. Implementation of clinical guidelines of chemotherapy protocol through C-CO improves physician acceptance, brings about marked changes in practice, and significantly improves the quality of patient care.
